Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome
Despite the beneficial effect of myo-inositol on metabolic, hormonal, and reproductive parameters of polycystic ovary syndrome (PCOS) patients, 28% to 38% could be resistant to this treatment. The combination with the milk protein α-lactalbumin can be a useful therapeutic approach to overcome inosit...
Main Authors: | Zdravko Kamenov, Antoaneta Gateva, Simona Dinicola, Vittorio Unfer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/13/6/717 |
Similar Items
-
Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women
by: Mario Montanino Oliva, et al.
Published: (2018-05-01) -
Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome
by: Iñaki Lete, et al.
Published: (2024-12-01) -
Results of treatment with myo-Inositol and D-chiro inositol combination in ratio 5:1 in women with polycystic ovary syndrome
by: Tatiana A. Oboskalova, et al.
Published: (2020-12-01) -
Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials
by: Vittorio Unfer1,, et al.
Published: (2017-10-01) -
Myo-inositol pregravidal training use prospects in women with polycystic ovary syndrome and insulin resistance
by: O A Gromova, et al.
Published: (2014-02-01)